New federal guidelines may limit Covid vaccine access for millions in multiple states. Here are the states affected.

In a post on X, HHS Secretary Robert F. Kennedy said the FDA has cleared vaccines from Pfizer, Moderna and Novavax for use in ...

The Food and Drug Administration rescinded the emergency use authorization that made COVID-19 shots available for healthy ...

WASHINGTON (AP) — U.S. regulators approved Pfizer’s updated COVID-19 shot Wednesday but with limits that could complicate ...

The Food and Drug Administration has approved the 2025-2026 formulation of Nuvaxovid (COVID-19 Vaccine, Adjuvanted).

The US Food and Drug Administration approved updated Covid-19 vaccines but for a more limited group: adults age 65 and older ...

On August 27, 2025, Novavax announced that the U.S. FDA approved the Nuvaxovid 2025-2026 COVID-19 vaccine formula for adults 65 and older, as well as individuals ages 12-64 with underlying conditions ...

The FDA on Wednesday approved the updated COVID-19 vaccines for the 2025-2026 respiratory disease season, but with ...

The FDA's decision breaks sharply from previous policy, which recommended annual COVID-19 shots for nearly everyone 6 months ...

Financially, Novavax, Inc. (NASDAQ:NVAX) reported an unexpected net income of $107 million in Q2 2025, aided by milestone payments, cost reductions, and organizational efficiencies. The corporation ...

Novavax slid Thursday in its worst session in more than four months after laying out plans to refinance $225 million of debt, ...